Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Environment
Roche Secures DNA-Sequencing License
by Ann M. Thayer
October 16, 2011
| A version of this story appeared in
Volume 89, Issue 42
Roche has licensed technology developed by collaborators Stuart Lindsay of Arizona State University’s Biodesign Institute and Colin Nuckolls of the Columbia University Nanoscience Center. Roche will use the DNA-reading technology to build on work its 454 Life Sciences business has been doing with IBM to develop a single-molecule nanopore DNA sequencer. The scientists’ method eliminates the need to use chemical reagents. Roche and IBM hope to create a system that can decode an individual’s genome for less than $1,000.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter